Overpriced medical devices: Govt asks companies to submit MRP details

Amidst reports of rising prices of medical devices including stents, the Government has asked the companies to review their pricing and submit maximum retail price (MRP) details of their products to drug price regulator NPPA.

Pharmexcil sees $1.2 billion export hit from EU ban

India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.

Commerce Ministry takes steps to boost pharma exports, sets up committee

Pharmaceutical sector has huge potential in terms of increasing exports, the Commerce Ministry is taking many measures to boost overseas shipments, a ministry official said.

Govt approves FDI worth Rs 4,000 cr in pharma sector
Govt approves FDI worth Rs 4,000 cr in pharma sector

Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.

SC stays Delhi HC order till April 28 against Glenmark

Supreme Court today stayedtill April 28 the order of Delhi High Court barring Indian pharma major Glenmark Pharamceuticals from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed patent right.

Sun Pharma, Ranbaxy rise after regulatory nods for merger deal

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories today settled in the positive territory after regulatory nods paved the way for completion of their USD 4-billion merger.

FTC passes final order in USD 4 billion Sun-Ranbaxy deal

US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices.

Govt may set up new Ministry for pharmaceuticals sector

The government may establish a separate Ministry for the pharmaceuticals sector, which would comprise all departments that deal with issues related to the industry.

Sensex rebounds 68 pts as pharma, FMCG, banking shares rise

After taking a day's breather, markets today continued their upward journey with the benchmark Sensex rebounding over 68 points while the Nifty edged up 15 points on buying in pharma, FMCG, banking and auto shares amid sustained foreign fund inflows.

R&D activities in pharma may get tax boost in Budget

"There is an urgent need to boost R&D in the pharma sector. India is the hub of generic medicines. It contributes significantly to the country's total exports," the official added.

Glenmark Q3 net dips 47 pc at Rs 114.77 cr

Glenmark Pharmaceuticals today reported a 46.92 per cent dip in its consolidated net profit at Rs 114.77 crore for the quarter ended December 31, 2014 mainly due to forex losses and increased expenses.

Pharma exports to reach Rs 1.1 lakh cr by FY'16
Pharma exports to reach Rs 1.1 lakh cr by FY'16

The pharmaceutical industry continues to benefit from lower cost of research and production which aids manufacturing for exports, the report said.

Govt plans to bring all pharma related Depts under one roof

"We are working on one proposal to bring all the departments or government agencies which deals with the pharma sector under one single department," Minister of Chemicals and Fertilisers Ananth Kumar said.

Govt to rollout bulk drug pharma policy within 15 days

Government on Thursday said it will rollout a new pharma policy for bulk drugs in 10-15 days which will help the sector grow manifold over the next 5-7 years.

A bitter pill as China crackdowns squeeze pharma margins

China`s fast-growing pharmaceutical market has squeezed profits and margins.

Nifty pares initial losses to regain 6,500-mark, up 11 points

Fag-end bouts of value buying in key counters of Pharma, FMCG, Auto and infra lifted the benchmark to regain 6,500 level, gaining a modest 11.10 points at the National Stock Exchange (NSE) here on Friday .

US industry wants India designated Priority Foreign Country

Ramping up their anti-India campaign, an influential section of American businesses, in particular those from the pharma and manufacturing sectors, here on Monday urged the Obama Administration to designate India as a Priority Foreign Country.

Pharmaceutical Price Regulation - Is the government being two-faced?

Globally, a blazing battle rages on regarding governmental curbs on Big Pharma’s intellectual property rights so as to fulfill the obligation of making the human right to health a reality.

9 drug firms to be fined Rs 2500 cr for overpricing: Report

Soon, many big names in the pharma industry will have to bite a bitter pill of Rs 2500 crore as penalty for drugs overpricing.

Lupin to market MSD's pneumonia prevention vaccine in India

Drug major Lupin Thursday said it has inked an in-licensing agreement with pharma company MSD, under which the company will market MSD's pneumonia prevention vaccine under a different brand name in India.